Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds
Phase 1
Completed
- Conditions
- BurnsWound Healing
- Interventions
- Device: Procellera (Bioelectric Wound Dressing)Device: Opsite (Transparent Adhesive Dressing)
- Registration Number
- NCT01061502
- Lead Sponsor
- Vomaris Innovations
- Brief Summary
The purpose of this study is to determine whether the use of a bioelectric wound dressing is effective in the healing of skin graft donor site wounds.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
- Wounds resulting from skin graft
- Split thickness wound
- Wound size greater than 2x2 cm
- Wounds must be ≥5 cm away from all other wounds
- Participant agrees to participate in follow-up evaluation
- Participant must be able to read and understand informed consent, and sign the informed consent
Exclusion Criteria
- Concurrent participation in another clinical trial that involves an investigational drug or device that would interfere with this study
- Participant is to receive another topical antimicrobial agent other than the study dressing
- Participant with sensitivity or adverse reactions to silver or zinc
- Pregnancy or nursing an infant or child
- Immunosuppression
- Active or systemic infection
- Peripheral vascular occlusive disease
- Collagen vascular disease
- Connective tissue disease
- Participant undergoing active cancer chemotherapy
- Chronic steroid use
- Decision impairment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Procellera Wound Dressing Procellera (Bioelectric Wound Dressing) Dressing indicated for partial and full-thickness wounds. Dressing changes every 5-7 days, more frequently if needed Opsite Transparent Adhesive Dressing Opsite (Transparent Adhesive Dressing) Polyurethane film dressing. Dressing changes every 5-7 days, more frequently if needed
- Primary Outcome Measures
Name Time Method To compare epithelialization over time 3 months
- Secondary Outcome Measures
Name Time Method To compare patient reported perception of pain 3 months To compare scarring 3 months
Trial Locations
- Locations (1)
Blodgett Hospital
🇺🇸Grand Rapids, Michigan, United States